Cancer Drug Zevalin May Finally Thrive Under Spectrum

The small oncology company may be able to succeed with the non-Hodgkin lymphoma drug where others have failed.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet